Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lp(A)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01924858
What this trial is testing

A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 4
Testing effectiveness (Phase 2)Looking for participantsNCT05646381
What this trial is testing

Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis

Who this might be right for
Aortic Stenosis
Novartis Pharmaceuticals 502
Not applicableWithdrawnNCT04993664
What this trial is testing

Influence of Pelacarsen on Patients After Myocardial Infarction With High Lp(a) Values (PEMILA)

Who this might be right for
Acute Coronary SyndromeLipoproteinemiaInflammation+1 more
University Medical Centre Ljubljana
Post-approval studies (Phase 4)Study completedNCT02054455
What this trial is testing

Proton Pump Inhibitors and Gastrointestinal Symptoms

Who this might be right for
Gastrointestinal SymptomsSmall Intestinal Overgrowth
Federico II University 100
Not applicableLooking for participantsNCT06062446
What this trial is testing

A Prospective Study of a Modified Lumbar Puncture (LP) Procedure That Reduces Post-Lumbar Puncture Headaches (PLPH) in Patients

Who this might be right for
Post-Lumbar Puncture Headache
The University of Texas Health Science Center, Houston 100
Not applicableStudy completedNCT01753232
What this trial is testing

Safety and Efficacy of the DALI LDL-adsorber and MONET Lipoprotein Filter

Who this might be right for
Hypercholesterolemia, FamilialLIPOPROTEIN TYPES--Lp SYSTEM Lp(a) HYPERLIPOPROTEINEMIA
Fresenius Medical Care Deutschland GmbH 108
Not applicableUnknownNCT05496790
What this trial is testing

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

Who this might be right for
Acute Coronary SyndromeLipoprotein DisorderAcute Myocardial Infarction+1 more
University of Campania Luigi Vanvitelli 1,000
Not applicableUnknownNCT05090878
What this trial is testing

Atherogenic Lipoproteins in Ischemic Stroke

Who this might be right for
Ischemic Stroke
University Hospital, Basel, Switzerland 500
Not applicableStudy completedNCT02976818
What this trial is testing

Lp(a) and Aortic Valve Calcification

Who this might be right for
Heterozygous Familial Hypercholesterolemia
Laval University 173
Large-scale testing (Phase 3)Study completedNCT00233688
What this trial is testing

Study of the Endovascular QUANTUM LP™ Stent Graft System in Abdominal Aortic Aneurysms (AAA)

Who this might be right for
Abdominal Aortic Aneurysm
Cordis US Corp. 300
Not applicableLooking for participantsNCT07508007
What this trial is testing

Impact of Implementation Strategies on Lp(a) Testing in Secondary Care Settings

Who this might be right for
Implementing EAS/ESC Guideline Recommendation on Lp(a) Testing in Routine Practice
Novartis Pharmaceuticals 4,500
Not applicableWithdrawnNCT01064934
What this trial is testing

Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)

Who this might be right for
Hyperlipoproteinemia(a)Progressive Cardiovascular Disease
Charite University, Berlin, Germany
Large-scale testing (Phase 3)Enrolling By InvitationNCT06782646
What this trial is testing

Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine

Who this might be right for
Hyperlipidemia
The University of Hong Kong 100
Testing effectiveness (Phase 2)Study completedNCT00534859
What this trial is testing

PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCI

Who this might be right for
Patients Undergoing High Risk PCI.
Abiomed Inc. 28
Large-scale testing (Phase 3)Study completedNCT02729025
What this trial is testing

Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia
Amgen 129
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Post-approval studies (Phase 4)Study completedNCT01604811
What this trial is testing

Exploratory Study of L.S.E.S.r. (LipidoSterolic Extract of Serenoa Repens)(PERMIXON® 160 mg Hard Capsule) Versus Tamsulosine LP Activity on Inflammation Biomarkers in Urinary Symptoms Related to BPH (Benign Prostatic Hyperplasia)

Who this might be right for
Benign Prostatic Hyperplasia (BPH)
Pierre Fabre Medicament 206
Early research (Phase 1)Active Not RecruitingNCT07745114
What this trial is testing

SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)

Who this might be right for
Healthy ParticipantsElevated Lp(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd. 144
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Early research (Phase 1)Study completedNCT05258747
What this trial is testing

A Crossover Bioequivalence Study of Olaparib Tablets, 150 mg (Lek Pharmaceuticals d.d.) and Lynparza® (Olaparib) Tablets 150 mg (AstraZeneca Pharmaceuticals LP), in Patients With Breast Cancer Gene (BRCA) Mutated Ovarian Cancer, Recurrent Ovarian Cancer or Metastatic Breast Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Sandoz 70
Next Page